USA Rare Earth Runs as Stillwater Goes Live and $1.6B CHIPS Deal Nears Close

The Catalyst

The 13% move didn't come from new news. It came from amplification. On April 2, Motley Fool published an analysis walking through the late-March catalysts — Stillwater Phase 1a commissioning and Q4 2025 earnings — framing them as reasons USAR might be a buy. TipRanks ran similar coverage. The stock responded with a 6.4% single-session jump that continued into April 3.

The underlying milestones are real. On March 26, USAR announced it had successfully commissioned Phase 1a of its commercial magnet production line in Stillwater, Oklahoma — a 310,000+ square foot facility with over 100 employees, now cleared to begin fulfilling customer orders for sintered NdFeB permanent magnets in Q2 2026. Four days later, the company reported Q4 2025 earnings showing its first-ever revenue: $1.64 million. Small in absolute terms, but it moved USAR from a zero-revenue pre-production story to one with actual sales. The two-day lag between the news and the price action is typical for a stock with limited analyst coverage that relies on financial media to distribute its narrative to retail.

The Balance Sheet Behind the Story

Revenue is $1.64 million against a $59.5 million full-year operating loss and a $297.6 million net loss. The gap is enormous but expected for a company in heavy buildout mode. What matters more right now is the balance sheet: USAR ended 2025 with $359.9 million in cash, and after the $1.5 billion PIPE that closed in January 2026, the current cash position is roughly $1.75 billion with no debt.

That runway is long enough to fund operations well beyond any near-term milestone. Wall Street expects $50.8 million in revenue for 2026 and $289.7 million for 2027 as Stillwater ramps — aggressive numbers that require Phase 1a to deliver on its 600 mtpa target by Q4 2026 and Phase 1b to arrive on schedule in Q1 2027. Canaccord Genuity cut its price target from $33 to $29 but maintained its buy rating. At a $3.5 billion market cap with $1.75 billion in cash, investors are pricing the business itself at roughly $1.75 billion — a bet on execution, not assets in the ground.

The Stillwater Question

There's a wrinkle worth noting. On March 29, The OK Post reported that the Stillwater facility holds a Certificate of Occupancy only for lab and storage areas — not the production floor. According to a source with firefighting credentials cited in the report, required inert gas suppression systems are not yet installed, and the facility is currently running hydrogen for testing without completed fire suppression infrastructure rated for H-1 Hazard Occupancy. A subsequent SEC filing reportedly noted that the facility "has not commenced producing and selling" magnets — language that sits awkwardly next to the March 26 press release announcing commissioning.

The distinction between "commissioned" and "production-ready" matters. USAR's Tax Increment Financing agreement tied $8.2 million in Oklahoma taxpayer funds to a March 31 development deadline. It also matters for the CHIPS deal: if the government's milestone framework requires demonstrated production rather than equipment commissioning, a gap between the two could complicate the April timeline. None of this necessarily derails the thesis, but it introduces execution ambiguity at the exact moment the market is pricing in execution certainty.

What April Decides

The headline event is still ahead. In the Q4 earnings release, management stated that definitive documentation for the $1.6 billion Department of Commerce CHIPS funding is expected to be completed this month. That would convert the January Letter of Intent into a binding agreement: $277 million in direct federal investment plus a $1.3 billion senior secured loan. If it closes, USAR becomes arguably the most heavily government-backed rare earth play in the Western Hemisphere.

The broader context makes the timing interesting. Domestic rare earth supply chain development has bipartisan political support, and the CHIPS and Science Act specifically targets critical mineral processing as a national security priority. But USAR's own commissioning press release carried going-concern language from auditors, and the company's hydromet demonstration facility in Colorado still needs to run 2,000-4,000 hours of solvent-extraction testing before the commercial plant design can be finalized. The stock at $16 is pricing in a lot of things going right in sequence. April will show whether they are.

Trading on Hyperliquid

Trade USAR on Hyperliquid with up to 10x leverage.